Opinion
Video
Author(s):
Panelists discuss how the prevalence of metastatic castration-sensitive prostate cancer (mCSPC) has been increasing, potentially influenced by changes in prostate-specific antigen screening recommendations and rising diagnoses of metastatic hormone-sensitive prostate cancer.
Video content above is prompted by the following:
What is the prevalence of mCSPC? What trends have emerged in recent years?